Saba Capital Management »

Teva Pharmaceutical Industries shares owned by Saba Capital Management

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 131k 14.11
2023-12-31 $1.9M 180k 10.44
2023-09-30 $1.9M 189k 10.20
2023-06-30 $1.9M 253k 7.53
2023-03-31 $1.9M 211k 8.85
2022-12-31 $331k 36k 9.12
2021-06-30 $44M 4.4M 9.90
2019-09-30 $13M 1.8M 6.87

More positions owned by Saba Capital Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Adams Express Company (ADX)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
ClearBridge Energy MLP Fund (EMO)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Clearbridge Mlp And Mids (CEM)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Nuveen Nj Div Advantage Mun (NXJ)
Mainstay Cbre Global (MEGI)
American Airls Put Option (AAL)
Blackrock Calif Mun Income T Sh Ben Int (BFZ)

View all positions for Saba Capital Management

Top funds holding Teva Pharmaceutical Industries

BlackRock
Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Clal Insurance Enterprises Holdings
Menora Mivtachim Holdings
Exor Investments
FMR
Rubric Capital Management
Citigroup
Millennium Management
AustralianSuper Pty
Citadel Advisors
Geode Capital Management
Susquehanna International

View all funds holding Teva Pharmaceutical Industries